Diamond Biofund Inc. (TWSE: 6901)
Financials · Capital Markets · TW
NT$17.30
+4.85% today · -16.4% 1Y
Diamond Biofund Inc. (TWSE: 6901) operates in the Capital Markets industry within the Financials sector. The company is valued at $463.62M and employs 29 people.
Over the last twelve months the share price has lost 16.4%, trading between 12.05 and 22.40.
Tweenvest scores Diamond Biofund Inc. across four factors: quality 38/100, value 46/100. Its strongest factor is value.
6901 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $463.62M
- Revenue (TTM)
- $95.04M
- P/E
- 5.11
- EPS
- 3.39
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- NT$22.40
- 52-week low
- NT$12.05
- Avg volume (3M)
- —
- Shares outstanding
- 853.36M
- Employees
- 29
- Next earnings
- —
About Diamond Biofund Inc.
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
- ISIN
- TW0006901002
- Founded
- 2013
- Listed since
- Sep 11, 2023
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $216.89 | +1.31% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,059.32 | +2.22% |
Figures last refreshed Aug 18, 2026.